Outlook is neutral, with stock confined to a range of ±5%
Strategy has +44% ROI potential and 6% overvalued
LLY Eli Lilly And Company973.88+54.11 (+5.9%)
Outlook is neutral, with stock confined to a channel of ±4%
Strategy has +68% ROI potential and 11% overvalued
Outlook is neutral, with stock confined to a span of ±6%
Strategy has +56% ROI potential and 3% overvalued
Outlook is neutral, with stock confined to a span of ±4%
Strategy has +40% ROI potential and 4% overvalued
Outlook is neutral, with stock confined to a range of ±3%
Strategy has +69% ROI potential and 7% overvalued
